Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits ... % spike in deaths in the 12 months to April 2021 to nearly 100,000. The latest deal still ...

Purdue Pharma will pay more ... "This is $1.4 billion more than the settlement reached in 2022, and $3.1 billion more than the settlement Connecticut rejected in 2021," said Tong.

Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve ... filed for bankruptcy themselves. That offer also came under widespread criticism ...

Purdue Pharma ... billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid addiction crisis in the US. Protesters in 2021, above.

Jan 13 (Reuters) - The Sackler family owners of Purdue Pharma ... settlement would provide compensation to all claimants from Purdue, the newspaper reported. Additionally, the Sackler family would ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

AP — Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful ...

FILE PHOTO: A pharmacist holds a bottle OxyContin made by Purdue Pharma at a pharmacy in Provo, Utah ...

Purdue Pharma, owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin Staff and wire, The Register-Herald, Beckley, W.Va. Fri, January 24, 2025 at 4:59 AM UTC ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

NEW YORK, Jan 23 (Reuters) - Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin ...